These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19735500)

  • 21. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
    Win N; Sinha S; Lee E; Mills W
    Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibody formation after alloimmunization inducing bystander immune hemolysis.
    Mota M; Bley C; Aravechia MG; Hamerschlak N; Sakashita A; Kutner JM; Castiho L
    Immunohematology; 2009; 25(1):9-12. PubMed ID: 19856726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges in transfusion of patients with sickle cell disease.
    van Draat KF
    Transfus Apher Sci; 2013 Apr; 48(2):165. PubMed ID: 23809817
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.
    Boonyasampant M; Weitz IC; Kay B; Boonchalermvichian C; Liebman HA; Shulman IA
    Transfusion; 2015 Oct; 55(10):2398-403. PubMed ID: 25989361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High multi-cytokine levels are not a predictive marker of alloimmunization in transfused sickle cell disease patients.
    Tatari-Calderone Z; Fasano RM; Miles MR; Pinto LA; Luban NL; Vukmanovic S
    Cytokine; 2014 Jul; 68(1):59-64. PubMed ID: 24746244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease.
    McGlennan AP; Grundy EM
    Anaesthesia; 2005 Jun; 60(6):609-12. PubMed ID: 15918834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood transfusion in sickle cell disease.
    Marouf R
    Hemoglobin; 2011; 35(5-6):495-502. PubMed ID: 21981466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of sickle cell alloimmunization.
    Yazdanbakhsh K
    Transfus Clin Biol; 2015 Aug; 22(3):178-81. PubMed ID: 26056038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis.
    Seeyave D; Desai N; Miller S; Rao SP; Piecuch S
    J Natl Med Assoc; 2006 Oct; 98(10):1697-9. PubMed ID: 17052065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients.
    Vingert B; Tamagne M; Habibi A; Pakdaman S; Ripa J; Elayeb R; Galacteros F; Bierling P; Ansart-Pirenne H; Bartolucci P; Noizat-Pirenne F
    Eur J Immunol; 2015 Jun; 45(6):1868-79. PubMed ID: 25763868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Murine models in blood transfusion: allo-immunization, hemolysis].
    Desmarets M; Noizat-Pirenne F
    Transfus Clin Biol; 2011 Apr; 18(2):115-23. PubMed ID: 21398162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension and a seizure following transfusion in an adult with sickle cell anemia.
    Warth JA
    Arch Intern Med; 1984 Mar; 144(3):607-8. PubMed ID: 6703831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A complicated course of transfusion. Late hemolytic transfusion reaction and T-activation of erythrocytes].
    Poulsen LO; Lylloff K
    Ugeskr Laeger; 1987 Aug; 149(35):2331-2. PubMed ID: 3451463
    [No Abstract]   [Full Text] [Related]  

  • 35. Delayed hemolytic transfusion reactions. An often-missed entity.
    Solanki D; McCurdy PR
    JAMA; 1978 Feb; 239(8):729-31. PubMed ID: 621892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
    Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
    Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risks associated with transfusions in sickle cell disease: delayed hemolytic transfusion reaction].
    Habibi A; Noizat-Pirenne F
    Rev Prat; 2014 Oct; 64(8):1128-9. PubMed ID: 25510142
    [No Abstract]   [Full Text] [Related]  

  • 38. Rheologic behavior of sickle and normal red blood cell mixtures in sickle plasma: implications for transfusion therapy.
    Alexy T; Pais E; Armstrong JK; Meiselman HJ; Johnson CS; Fisher TC
    Transfusion; 2006 Jun; 46(6):912-8. PubMed ID: 16734807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhemolysis syndrome in sickle cell disease.
    Win N
    Expert Rev Hematol; 2009 Apr; 2(2):111-5. PubMed ID: 21083443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.